drugset / Trial / NCT01222572
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
In this research study the investigators are looking for the highest dose of a stereotactic radiation boost that can be given safely. Because stereotactic radiation is so precise, the investigators are testing whether it can be used to increase the dose to the primary tumor without significantly increasing the side effects the participant experiences; the goal is to improve the likelihood of killing the tumor.
Timeline
- Start
- 2010-12
- Primary completion
- 2012-03
- Completion
- 2012-10
Outcome
Outcome not reported
Stopped (Enrollment): “Slow accrual due to restrictive eligibility criteria”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cisplatin | Other / unclassified | 50 mg/m2 | — |
| Background | Etoposide | Small molecule | 50 mg/m2 | — |